P1437: NOVEL ERYTHROID ENHANCERS IMPROVE GENE THERAPY VECTORS FOR BETA-HEMOGLOBINOPATHIES

• N. Psatha,
• P. Sova,
• G. Georgolopoulos,
• M. Iwata,
• K. Paschoudi,
• A. Kirtsou,
• T. Ulyanova,
• J. A. Stamatoyannopoulos,
• E. Yannaki,
• T. Papayannopoulou,
• J. Vierstra

Affiliations

N. Psatha

1 Genetics, Development and Molecular Biology, Aristotle University of Thessaloniki, Thessaloniki, Greece

P. Sova

2 Altius Institute for Biomedical Sciences, Seattle, United States of America

G. Georgolopoulos

2 Altius Institute for Biomedical Sciences, Seattle, United States of America

M. Iwata

2 Altius Institute for Biomedical Sciences, Seattle, United States of America

K. Paschoudi

3 Aristotle University of Thessaloniki

A. Kirtsou

4 Gene and Cell Therapy Center, George Papanikolaou Hospital, Hematology Clinic-BMTU, Thessaloniki, Greece

T. Ulyanova

5 Hematology, University of Washington, School of Medicine, Seattle, United States of America

J. A. Stamatoyannopoulos

2 Altius Institute for Biomedical Sciences, Seattle, United States of America

E. Yannaki

4 Gene and Cell Therapy Center, George Papanikolaou Hospital, Hematology Clinic-BMTU, Thessaloniki, Greece

T. Papayannopoulou

5 Hematology, University of Washington, School of Medicine, Seattle, United States of America

J. Vierstra

2 Altius Institute for Biomedical Sciences, Seattle, United States of America